Negative spinal bone mineral density changes and subclinical ovulatory disturbances--prospective data in healthy premenopausal women with regular menstrual cycles
Subclinical ovulatory disturbances (anovulation or short luteal phases within normal-length menstrual cycles) indicate lower progesterone-to-estrogen levels. Given that progesterone plays a bone formation role, subclinical ovulatory disturbances may be associated with bone loss or less than expected bone gain. Our purpose was to perform a meta-analysis of prospective studies in healthy premenopausal women to determine the overall relationship of subclinical ovulatory disturbances to change in bone mineral density. Two reviewers independently identified from serial literature searches 6 studies meeting inclusion criteria: a 2-year study in 114 young adult women, 2006-2009, Vancouver, Canada; a 2-year study in 189 premenopausal women, 2000-2005, Toronto, Canada; a single-cycle study in 14 young women, 1996-1997, Melbourne, Australia; an 18-month study in 53 women, 1990-1995, Santa Clara, California; a 4-year study in 27 women, 1988-1995, Vancouver, Canada; and a 1-year study in 66 women, 1985-1988, Vancouver, Canada. This meta-analysis included a combined sample size of 473 observations in 436 premenopausal women studied over 1-4 years and aged 14-47 years. The percentage of women with ovulatory disturbances varied significantly from 13% to 82%. Women with more frequent ovulatory disturbances had more negative percentage changes in spine bone mineral density (weighted mean difference = -0.86; P = 0.040) for random-effects analysis. There was significant heterogeneity among these 6 studies (I(2) = 80%). In summary, these data show that regularly menstruating women with more frequent ovulatory disturbances experience more negative changes in bone (approximately -0.9% per year). These cycles with silent estrogen/progesterone imbalance may be clinically important.
subclinical ovulatory disturbances bone loss, anovulation bone mineral density, short luteal phase osteoporosis risk, progesterone bone formation, silent ovulation problems bone health, regular cycles low progesterone bone, premenopausal bone loss hormonal causes, cycle charting bone density, estrogen progesterone imbalance bone, menstrual cycle bone metabolism, luteal phase deficiency bone loss, ovulatory dysfunction osteoporosis premenopausal
Cite this article
Danni Li, Christine L Hitchcock, Susan I Barr, Tricia Yu, & Jerilynn C Prior (1900). Negative spinal bone mineral density changes and subclinical ovulatory disturbances - prospective data in healthy premenopausal women with regular menstrual cycles. *Epidemiologic reviews*, *36*(1), 137-147. https://doi.org/10.1093/epirev/mxt012
Danni Li, Christine L Hitchcock, Susan I Barr, Tricia Yu, Jerilynn C Prior. Negative spinal bone mineral density changes and subclinical ovulatory disturbances - prospective data in healthy premenopausal women with regular menstrual cycles. Epidemiol Rev. 1900;36(1):137-147. doi:10.1093/epirev/mxt012
Danni Li, et al. "Negative spinal bone mineral density changes and subclinical ovulatory disturbances - prospective data in healthy premenopausal women with regular menstrual cycles." *Epidemiologic reviews*, vol. 36, no. 1, 1900, pp. 137-147.
Cognitive dietary restraint (CDR) is the
perception
of limiting food intake to achieve/maintain a perceived ideal body weight. The objective of this 2‐yr prospective study was to determine if women wi...
Hilgers TW, 2004The Medical and Surgical Practice of NaProTECHNOLOGY
Bone Health > Menstrual Cycle Effects > Ovulatory DisturbancesBone Health > Menstrual Cycle Effects > AmenorrheaBone Health > Progesterone > Bone Formation
Prior JC, 2018
Open Access
Climacteric : the Journal of the International Menopause Society
Estradiol (E2) is women's dominant 'bone hormone' since it is essential for development of adolescent peak bone mineral density (BMD) and physiological levels prevent the rapid (3-week) bone resorptio...
Bone Health > Progesterone > Clinical EvidenceReproductive Endocrinology > Progesterone > Clinical EffectsBone Health > Menstrual Cycle Effects > Ovulatory Disturbances